Tirzepatide: The Best Option for Effective Weight Loss?

With the arrival of new and potent medications for the treatment of obesity, many patients in Belo Horizonte are wondering: with so many options, is Tirzepatide (Mounjaro®) really the best choice? The answer, based on the most robust scientific evidence available to date, points to a clear yes in terms of potency and effectiveness in weight loss.

This detailed guide explores the reasons why Tirzepatide is at the top of the list of pharmacological treatments for weight loss, comparing it to other options and explaining why it is considered a revolution in the field.

The Key Difference That Defines Superiority: Dual Hormonal Action

What makes Tirzepatide superior is not a detail, but a fundamental innovation in its mechanism of action.

Other Medications (Semaglutide, Liraglutide): These act as agonists of a single hormone, GLP-1. They mimic the action of this intestinal hormone, which promotes satiety and reduces hunger.

Tirzepatide: It is the first and only dual agonist, acting simultaneously on GLP-1 and GIP receptors. GIP is another intestinal hormone that, in synergy with GLP-1, not only amplifies the feeling of satiety, but also significantly improves the metabolism of fats and sugars.

This action on two hormonal fronts is what gives Tirzepatide its unprecedented potency, resulting in more pronounced weight loss.

The Proof in Numbers: A Comparison of Effectiveness Clinic

The most objective way to determine which is the “best” option in terms of results is to compare data from major clinical studies.

Average Weight Loss (Maximum Doses):

Medication

Active ingredient

Average Weight Loss

Mounjaro®

Tirzepatide

~20.9%

Wegovy®

Semaglutide

~14.9%

Saxenda®

Liraglutide

~8%

Source: Reference clinical studies (SURMOUNT-1, STEP 1, SCALE).

What does this mean in practice?

For a person weighing 100 kg, the expected average weight loss is:

With tirzepatide: Almost 21 kg.

With Semaglutide: Almost 15 kg.

With Liraglutide: 8 kg.

The difference is substantial and clinically very significant.

The Head-to-Head: Tirzepatide vs. Semaglutide

The SURMOUNT-5 study pitted the two most potent drugs against each other. The results confirmed the superiority of tirzepatide: patients who used it lost considerably more weight than those who used semaglutide over the same period. Furthermore, a much larger proportion of patients in the tirzepatide group achieved more ambitious weight loss goals (such as losing 20% or 25% of body weight).

[Comparative graph showing the weight loss curves of Tirzepatide, Semaglutide, and Liraglutide, highlighting the superiority of Tirzepatide]

Beyond Weight Loss: Enhanced Metabolic Benefits

The superiority of Tirzepatide is not limited to weight loss. Its potent dual action also translates into better results for overall metabolic health, including:

Superior glycemic control in patients with diabetes or prediabetes.

More pronounced improvement in cholesterol and triglyceride levels.

Positive impact on reducing fat in the liver.

Lowering blood pressure.

This makes it a particularly valuable therapeutic option for patients dealing with metabolic syndrome associated with obesity.

“"Better" for Whom? The Importance of Medical Evaluation

Although it is the most potent option in terms of average results, the "best" option for you is a decision that should be made in conjunction with your endocrinologist in Belo Horizonte. Factors such as your health history, comorbidities, tolerance to side effects, and even the cost of treatment will be considered.

For some patients, more moderate weight loss, such as that provided by liraglutide or semaglutide, may be sufficient and adequate. However, for those who require more substantial weight loss to reverse serious comorbidities or who have not responded to other treatments, tirzepatide establishes itself as the first-line pharmacological option.

Conclusion:

Based on current scientific evidence, tirzepatide is, in fact, the most effective pharmacological option available for weight loss. Its innovative dual mechanism of action provides superior results in both reducing body weight and improving metabolic health, establishing a new standard of treatment for obesity. The final choice, however, will always be personalized and guided by a medical specialist, ensuring the safety and suitability of the treatment to your individual profile.